We have shown that GSK-3 inhibitors activate JNK in gastric adenocarcinoma cells, which regulate negatively on TRAIL-induced apoptosis, thereby providing a anti-apoptotic signal. The gene discussed is TNFSF10; the disease is gastric adenocarcinoma.